Emerging Infectious Diseases (Aug 2017)

mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal

  • Marta Tacão,
  • Rafael dos Santos Tavares,
  • Pedro Teixeira,
  • Inês Roxo,
  • Elmano Ramalheira,
  • Sónia Ferreira,
  • Isabel Henriques

DOI
https://doi.org/10.3201/eid2308.170162
Journal volume & issue
Vol. 23, no. 8
pp. 1419 – 1421

Abstract

Read online

Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes.

Keywords